Dr. Medha Barbhaiya graduated from Columbia University where she majored in the Biological Sciences. She received her medical degree from Weill Cornell Medical College, and completed her residency in internal medicine at New York Presbyterian-Weill Cornell Medical College. During her rheumatology fellowship at Brigham and Women’s Hospital in Boston, Dr. Barbhaiya obtained a Master’s in Public Health degree from the Harvard T.H. Chan School of Public Health. She also received a Distinguished Fellow Award from the American College of Rheumatology and a Scientist Development Award from the Rheumatology Research Foundation. After completing her rheumatology fellowship, Dr. Barbhaiya joined the Brigham and Women’s Hospital and Harvard Medical School faculty as a rheumatologist and clinical researcher, during which time she was also a recipient of the Brigham and Women’s Faculty Career Development Award.
In 2017, Dr. Barbhaiya joined the Hospital for Special Surgery and Weill Cornell Medical College as a rheumatologist and clinical researcher and was also a recipient of an Investigator Award from the Rheumatology Research Foundation. Her research interests focus on studying environmental and lifestyle risk factors and outcomes related to rheumatic diseases such as systemic lupus erythematosus and antiphospholipid syndrome. Dr. Barbhaiya specializes in the treatment of systemic lupus erythematosus, antiphospholipid syndrome, inflammatory arthritis, undifferentiated connective tissue disease, pregnancy, vasculitis, scleroderma, Sjogren’s syndrome, and Raynaud’s, along with other rheumatologic conditions.
Lupus and APS Center of Excellence
Barbara Volcker Center for Women and Rheumatic Diseases
Rheumatology Reproductive Health Program
If your insurance is not listed, please call our office if you have questions regarding your insurance coverage. If you have out-of-network benefits, then your insurance may reimburse you for a portion of your office visit. We will work with you and your insurance to minimize your out-of-pocket costs. Financial assistance may be available for patients in need.
Attending Physician, Hospital for Special Surgery
Assistant Professor of Medicine, Weill Cornell Medical College
Board Certification in Rheumatology, American Board of Internal Medicine
Board Certification in Internal Medicine, American Board of Internal Medicine
Musculoskeletal Ultrasound Certification, US School of North American Rheumatologists
Super Doctors® Rising Stars 2019-2021, 2023
Rheumatology Research Foundation, Investigator Award, 2018
Antiphospholipid Syndrome Abstract Recognition Young Scholar Award, APS Foundation of America, 2016
ACR Distinguished Fellow Award, American College of Rheumatology, 2015
Brigham and Women’s Faculty Career Development Award, 2016
Rheumatology Research Foundation, Scientist Development Award, 2015APS ACTION Young Scholar Award 2015
ACR REF/Abbott Medical Resident Research Award, American College of Rheumatology, 2011
Education: MD, Weill Medical College of Cornell University, New York, NY, 2009
MPH, Harvard T.H. Chan School of Public Health, Boston, MA, 2015
Internship: NewYork-Presbyterian Hospital - Weill Cornell, New York, NY
Residency: NewYork-Presbyterian Hospital - Weill Cornell, New York, NY
Fellowship: Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 2015
English
For all publications, please see the PubMed listing.
HSS has a long history of supporting appropriate relationships with industry because they advance HSS's mission to provide the highest quality patient care, improve patient mobility, and enhance the quality of life for all, and to advance the science of orthopedic surgery, rheumatology, and their related disciplines through research and education.
As of August 22, 2024, Dr. Barbhaiya reported no relationships with the healthcare industry.
HSS and its physicians make this information available to patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest and Commitment Policy prohibits physicians from collecting royalties on products they develop that are used on patients at HSS.
